Institute of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, People's Republic of China.
Lab Invest. 2013 Jul;93(7):748-59. doi: 10.1038/labinvest.2013.63. Epub 2013 Apr 29.
Hypoxia-induced pulmonary hypertension (PH), which is characterized by vasoconstriction and subsequent structural remodeling of blood vessels, is an important event in chronic obstructive pulmonary disease patients and in people living at high altitudes. Hypoxia-inducible factor-1α (HIF-1α) and its regulator four-and-a-half LIM (Lin-11, Isl-1 and Mec-3) domain 1 (Fhl-1) have important roles in hypoxia-induced PH. MicroRNA-206 (miR-206) is critical for myogenesis and related diseases; however, the role of miR-206 in hypoxia-induced PH is unknown. miR-206 expression was evaluated in a hypoxic rat model and in cultured hypoxic pulmonary artery smooth muscle cells (PASMCs) using real-time quantitative PCR (RT-qPCR). HIF-1α and Fhl-1 expression were evaluated using RT-qPCR, western blotting, immunohistochemistry and immunofluorescence. The function of miR-206 was assessed by transfecting miR-206 mimics and inhibitors. Dual-luciferase reporter gene assays and western blotting were performed to validate the target genes of miR-206. siRNA targeted against Fhl-1 was used to investigate the effect of Fhl-1 on miR-206. Flow cytometry was used to detect the cell cycle phase distribution in each group of PASMCs. Significant downregulation of miR-206 in hypoxic lung tissue and PASMCs was identified, whereas HIF-1α and Fhl-1 were upregulated in these samples. The expression of miR-206 in the serum was different from that in the lung tissue. Transfection of pre-miR miR-206 in hypoxic conditions led to increased expression of HIF-1α and Fhl-1 rather than abolishing hypoxia-induced HIF-1α and Fhl-1, as was expected, and promoted the entry of cells into the S phase and enhanced PASMC proliferation. Fhl-1-targeted siRNA in PASMC prevented cell proliferation and led to an increased proportion of cells in the G1 phase without altering miR-206 expression. Bioinformatic analysis and dual-luciferase reporter gene assays revealed direct evidence for miR-206 targeting of HIF-1α. In conclusion, hypoxia-induced downregulation of miR-206 promotes PH by targeting the HIF-1α/Fhl-1 pathway in PASMCs. miR-206 could be a triggering factor of early stage of hypoxia-induced PH.
低氧诱导性肺动脉高压(PH)的特征为血管收缩及随后的血管结构重塑,是慢性阻塞性肺疾病患者和居住在高海拔地区人群的重要事件。低氧诱导因子-1α(HIF-1α)及其调节因子四和半 LIM(Lin-11、Isl-1 和 Mec-3)结构域 1(Fhl-1)在低氧诱导性 PH 中发挥重要作用。微小 RNA-206(miR-206)在肌发生和相关疾病中至关重要;然而,miR-206 在低氧诱导性 PH 中的作用尚不清楚。采用实时定量 PCR(RT-qPCR)评估低氧大鼠模型和培养的低氧肺动脉平滑肌细胞(PASMCs)中的 miR-206 表达。采用 RT-qPCR、western blot、免疫组化和免疫荧光检测 HIF-1α 和 Fhl-1 的表达。通过转染 miR-206 模拟物和抑制剂评估 miR-206 的功能。进行双荧光素酶报告基因检测和 western blot 验证 miR-206 的靶基因。用靶向 Fhl-1 的 siRNA 研究 Fhl-1 对 miR-206 的影响。采用流式细胞术检测各组 PASMC 的细胞周期分布。在低氧肺组织和 PASMCs 中发现 miR-206 显著下调,而这些样本中 HIF-1α 和 Fhl-1 上调。血清中的 miR-206 表达与肺组织不同。在低氧条件下转染 pre-miR miR-206 导致 HIF-1α 和 Fhl-1 的表达增加,而不是预期的消除低氧诱导的 HIF-1α 和 Fhl-1,促进细胞进入 S 期并增强 PASMC 增殖。PASMC 中的 Fhl-1 靶向 siRNA 可阻止细胞增殖,并导致 G1 期细胞比例增加,而不改变 miR-206 表达。生物信息学分析和双荧光素酶报告基因检测提供了 miR-206 靶向 HIF-1α 的直接证据。总之,低氧诱导的 miR-206 下调通过靶向 PASMC 中的 HIF-1α/Fhl-1 通路促进 PH。miR-206 可能是低氧诱导性 PH 早期的触发因素。